Dr. Lachman’s iPS Cell Research at Einstein Medical

By Kara Kilroy | February 24, 2021

Dr. Herbert Lachman, a scientist at the Albert Einstein College of Medicine, and a JdVS Medical Advisory Board Member is one of the first researchers to use iPS cells to study neurodevelopmental disorders. He is also one of the first to use a gene editing tool called CRISPR to introduce IDD and autism mutations into…

Read More
Boy in a wheelchair next to a lake

Original Paper on Intellectual Developmental Disorder with Gastrointestinal Difficulties and High Pain Threshold

By Kara Kilroy | February 10, 2021

Featured in

Read More
AJHG Logo

De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome

By Kara Kilroy | February 10, 2021

Featured in the American Journal of Human Genetics.

Read More